Related Experiment Video
Updated: Aug 28, 2025

Investigating Drivers of Antireward in Addiction Behavior with Anatomically Specific Single-Cell Gene Expression Methods
Published on: August 4, 2022
Transforming Management of Opioid Use Disorder with Universal Treatment
Rahul Gupta1, Rachel L Levine1, Javier A Cepeda1
1From the White House Office of National Drug Control Policy (R.G., J.A.C., D.R.H.) and the Office of the Assistant Secretary for Health, Office of the Secretary, Department of Health and Human Services (R.L.L.) - both in Washington, DC; and the Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore (J.A.C.).
No abstract available in PubMed .
Related Concept Videos
Opioid Analgesics: Synthetic and Semisynthetic Opioids
Analgesia and Pain Management
Opioid Analgesics: Morphine and Other Natural Cogeners
Drugs for Treatment of Diarrhea-Predominant IBS
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Drugs Affecting GI Tract Motility: Opioids as Antidiarrheal Agents
Opioids, widely used antidiarrheal agents, mitigate diarrhea by slowing down...
Opioid Receptors: Overview

